Pain medicine : the official journal of the American Academy of Pain Medicine
-
Botulinum toxin type A (BTX-A) has been widely used in many clinical disorders including migraine, cervical dystonia, etc. The use of BTX-A in neuropathic pain, however, is uncommon, and the application of the anti-nociceptive effect of botulinum toxin is emerging. Here we report a case of an 80-year-old man who suffered from severe pain of post-herpetic neuralgia which was refractory to the usual therapies. However, this neuropathic pain was dramatically relieved by multiple BTX-A injection and the pain relief lasted 52 days.
-
Editorial Comment
Pain management misstatements: ceiling effects, red and yellow flags.
-
Editorial Comment
Healthcare professionals and the DEA: trying to get back in balance.